CF Acquisition Corp VIII
Change company Symbol lookup
Select an option...
CFFE CF Acquisition Corp VIII
GVP GSE Systems Inc
FLGC Flora Growth Corp
PRPO Precipio Inc
LFLY Leafly Holdings Inc
QNRX Quoin Pharmaceuticals Ltd
INDP Indaptus Therapeutics Inc
RNAZ Transcode Therapeutics Inc
NEOV NeoVolta Inc
SYBX Synlogic Inc
Go

CF Acquisition Corp VIII is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and intends to acquire target companies in financial services, healthcare, real estate services, technology and software industries. The Company is not engaged in any business and has not generated any revenue.

Closing Price: $16.31

Day's Change: 1.51 (10.18%)

Bid: --

Ask: --

B/A Size: --

Day's High: 16.32

Day's Low: 13.92

Volume (Light) Volume: 29,217 10-day average volume: 191,071: 29,217

Kennedy-Wilson partners with Fairfax Financial to buy 95% interest in some Pacific Western Bank real estate construction loans

8:02 am ET June 5, 2023 (MarketWatch) Print

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

June 05, 2023 08:02 ET (12:02 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and